Literature DB >> 7826952

p59fyn tyrosine kinase regulates p56lck tyrosine kinase activity and early TCR-mediated signaling.

S K Lee1, A Shaw, S E Maher, A L Bothwell.   

Abstract

To study the role of p59fyn in T cell activation, we used antisense RNA to inhibit p59fyn expression in a T cell clone. Transfectants with reduced levels of p59fyn were functionally impaired in their responses to antigen, Con A+recombinant IL-1 and cross-linking with anti-TCR mAb. Induction of tyrosine phosphorylation on most intracellular substrates was greatly reduced. We also noted that the lck kinase activity was greatly reduced even though the amount of lck protein was equivalent to that present in parental D10 cells. Our results suggest that the protein tyrosine kinase p59fyn is critical in TCR-mediated signaling and also suggests that p59fyn may regulate p56lck tyrosine kinase activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7826952     DOI: 10.1093/intimm/6.10.1621

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  4 in total

1.  Activation of naïve CD4 T cells by anti-CD3 reveals an important role for Fyn in Lck-mediated signaling.

Authors:  Katsuji Sugie; Myung-Shin Jeon; Howard M Grey
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-01       Impact factor: 11.205

Review 2.  Regulation of cell signaling by the protein tyrosine phosphatases, CD45 and SHP-1.

Authors:  T Ulyanova; J Blasioli; M L Thomas
Journal:  Immunol Res       Date:  1997-02       Impact factor: 2.829

3.  The pool of preactivated Lck in the initiation of T-cell signaling: a critical re-evaluation of the Lck standby model.

Authors:  Ondřej Ballek; Jan Valečka; Jasper Manning; Dominik Filipp
Journal:  Immunol Cell Biol       Date:  2014-11-25       Impact factor: 5.126

4.  Mice lacking protein tyrosine kinase fyn develop a T helper-type 1 response and resistLeishmania major infection.

Authors:  K Yamakami; S Akao; K Wakabayashi; T Tadakuma; N Yoshizawa
Journal:  Environ Health Prev Med       Date:  2001-07       Impact factor: 3.674

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.